{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:25:29Z","timestamp":1791195929602,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T00:00:00Z","timestamp":1358121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T00:00:00Z","timestamp":1358121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,1,9]]},"DOI":"10.1038\/onc.2012.565","type":"journal-article","created":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T13:36:01Z","timestamp":1358170561000},"page":"203-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells"],"prefix":"10.1038","volume":"33","author":[{"given":"Y","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Hawthorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J K","family":"Cowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,14]]},"reference":[{"key":"BFonc2012565_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1172\/JCI24652","volume":"116","author":"M Jechlinger","year":"2006","unstructured":"Jechlinger M, Sommer A, Moriggl R, Seither P, Kraut N, Capodiecci P et al. Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest 2006; 116: 1561\u20131570.","journal-title":"J Clin Invest"},{"key":"BFonc2012565_CR2","doi-asserted-by":"publisher","first-page":"29491","DOI":"10.1074\/jbc.M110.136770","volume":"285","author":"E Johnson","year":"2010","unstructured":"Johnson E, Seachrist DD, DeLeon-Rodriguez CM, Lozada KL, Miedler J, Abdul-Karim FW et al. HER2\/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. J Biol Chem 2010; 285: 29491\u201329501.","journal-title":"J Biol Chem"},{"key":"BFonc2012565_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2011.06.007","volume":"311","author":"TC Chuang","year":"2011","unstructured":"Chuang TC, Hsu SC, Cheng YT, Shao WS, Wu K, Fang GS et al. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells. Cancer Lett 2011; 311: 11\u201319.","journal-title":"Cancer Lett"},{"key":"BFonc2012565_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z . Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52\u201367.","journal-title":"Cell"},{"key":"BFonc2012565_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3816\/CBC.2003.n.012","volume":"4","author":"PS Steeg","year":"2003","unstructured":"Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M . Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 2003; 4: 51\u201362.","journal-title":"Clin Breast Cancer"},{"key":"BFonc2012565_CR6","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1002\/ijc.25964","volume":"129","author":"Y Teng","year":"2011","unstructured":"Teng Y, Liu M, Cowell JK . Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells. Int J Cancer 2011; 129: 2825\u20132835.","journal-title":"Int J Cancer"},{"key":"BFonc2012565_CR7","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1158\/0008-5472.CAN-04-1911","volume":"65","author":"CB Pollock","year":"2005","unstructured":"Pollock CB, Shirasawa S, Sasazuki T, Kolch W, Dhillon AS . Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. Cancer Res 2005; 65: 1244\u20131250.","journal-title":"Cancer Res"},{"key":"BFonc2012565_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cell.2009.01.039","volume":"137","author":"M Adorno","year":"2009","unstructured":"Adorno M, Cordenonsi M, Montagner M, Dupont S, Wong C, Hann B et al. A Mutant-p53\/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 2009; 137: 87\u201398.","journal-title":"Cell"},{"key":"BFonc2012565_CR9","doi-asserted-by":"publisher","first-page":"21748","DOI":"10.1074\/jbc.M500503200","volume":"280","author":"K Sossey-Alaoui","year":"2005","unstructured":"Sossey-Alaoui K, Li X, Ranalli TA, Cowell JK . WAVE3-mediated cell migration and lamellipodia formation are regulated downstream of phosphatidylinositol 3-kinase. J Biol Chem 2005; 280: 21748\u201321755.","journal-title":"J Biol Chem"},{"key":"BFonc2012565_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.yexcr.2005.04.011","volume":"308","author":"K Sossey-Alaoui","year":"2005","unstructured":"Sossey-Alaoui K, Ranalli TA, Li X, Bakin AV, Cowell JK . WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp Cell Res 2005; 308: 135\u2013145.","journal-title":"Exp Cell Res"},{"key":"BFonc2012565_CR11","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.2353\/ajpath.2007.060975","volume":"170","author":"K Sossey-Alaoui","year":"2007","unstructured":"Sossey-Alaoui K, Safina A, Li X, Vaughan MM, Hicks DG, Bakin AV et al. Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol 2007a; 170: 2112\u20132121.","journal-title":"Am J Pathol"},{"key":"BFonc2012565_CR12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/sj.bjc.6605850","volume":"103","author":"Y Teng","year":"2010","unstructured":"Teng Y, Ren MQ, Cheney R, Sharma S, Cowell JK . Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases. Br J Cancer 2010; 103: 1066\u20131075.","journal-title":"Br J Cancer"},{"key":"BFonc2012565_CR13","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1038\/sj.onc.1205734","volume":"21","author":"K Sossey-Alaoui","year":"2002","unstructured":"Sossey-Alaoui K, Su G, Malaj E, Roe B, Cowell JK . WAVE3 an actin-polymerization gene, is truncated and inactivated as a result of a constitutional t (1;13)(q21;q12) chromosome translocation in a patient with ganglioneuroblastoma. Oncogene 2002; 21: 5967\u20135974.","journal-title":"Oncogene"},{"key":"BFonc2012565_CR14","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1242\/jcs.114.10.1801","volume":"114","author":"T Takenawa","year":"2001","unstructured":"Takenawa T, Miki H . WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement. J Cell Sci 2001; 114: 1801\u20131809.","journal-title":"J Cell Sci"},{"key":"BFonc2012565_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrm2069","volume":"8","author":"T Takenawa","year":"2007","unstructured":"Takenawa T, Suetsugu S . The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol 2007; 8: 37\u201348.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2012565_CR16","doi-asserted-by":"publisher","first-page":"26257","DOI":"10.1074\/jbc.M701484200","volume":"282","author":"K Sossey-Alaoui","year":"2007","unstructured":"Sossey-Alaoui K, Li X, Cowell JK . c-Abl-mediated phosphorylation of WAVE3 is required for lamellipodia formation and cell migration. J Biol Chem 2007b; 282: 26257\u201326265.","journal-title":"J Biol Chem"},{"key":"BFonc2012565_CR17","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1158\/0008-5472.CAN-09-2111","volume":"69","author":"DR Hurst","year":"2009","unstructured":"Hurst DR, Edmonds MD, Welch DR . Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 2009; 69: 7495\u20137498.","journal-title":"Cancer Res"},{"key":"BFonc2012565_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.4161\/cc.7.5.5547","volume":"7","author":"L Ma","year":"2008","unstructured":"Ma L, Weinberg RA . MicroRNAs in malignant progression. Cell Cycle 2008; 7: 570\u2013572.","journal-title":"Cell Cycle"},{"key":"BFonc2012565_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature06487","volume":"451","author":"SF Tavazoie","year":"2008","unstructured":"Tavazoie SF, Alarc\u00f3n C, Oskarsson T, Padua D, Wang Q, Bos PD et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147\u2013152.","journal-title":"Nature"},{"key":"BFonc2012565_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.molcel.2010.11.020","volume":"40","author":"C Levy","year":"2010","unstructured":"Levy C, Khaled M, Iliopoulos D, Janas MM, Schubert S, Pinner S et al. Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell 2010; 40: 841\u2013849.","journal-title":"Mol Cell"},{"key":"BFonc2012565_CR21","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1101\/gad.1820209","volume":"23","author":"DL Gibbons","year":"2009","unstructured":"Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ et al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev 2009; 23: 2140\u20132151.","journal-title":"Genes Dev"},{"key":"BFonc2012565_CR22","doi-asserted-by":"publisher","first-page":"7670","DOI":"10.1158\/0008-5472.CAN-11-0964","volume":"71","author":"MJ Schliekelman","year":"2011","unstructured":"Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q et al. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res 2011; 71: 7670\u20137682.","journal-title":"Cancer Res"},{"key":"BFonc2012565_CR23","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1158\/0008-5472.CAN-08-1942","volume":"68","author":"CP Bracken","year":"2008","unstructured":"Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008; 68: 7846\u20137854.","journal-title":"Cancer Res"},{"key":"BFonc2012565_CR24","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nature06783","volume":"452","author":"J Elm\u00e9n","year":"2008","unstructured":"Elm\u00e9n J, Lindow M, Sch\u00fctz S, Lawrence M, Petri A, Obad S et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452: 896\u2013899.","journal-title":"Nature"},{"key":"BFonc2012565_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593\u2013601.","journal-title":"Nat Cell Biol"},{"key":"BFonc2012565_CR26","doi-asserted-by":"publisher","first-page":"14910","DOI":"10.1074\/jbc.C800074200","volume":"283","author":"M Korpal","year":"2008","unstructured":"Korpal M, Lee ES, Hu G, Kang Y . The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008; 283: 14910\u201314914.","journal-title":"J Biol Chem"},{"key":"BFonc2012565_CR27","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1158\/0008-5472.CAN-10-0965","volume":"71","author":"A Ahmad","year":"2011","unstructured":"Ahmad A, Aboukameel A, Kong D, Wang Z, Sethi S, Chen W et al. Phosphoglucose isomerase\/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res 2011; 71: 3400\u20133409.","journal-title":"Cancer Res"},{"key":"BFonc2012565_CR28","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/embor.2008.74","volume":"9","author":"U Burk","year":"2008","unstructured":"Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008; 9: 582\u2013589.","journal-title":"EMBO Rep"},{"key":"BFonc2012565_CR29","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/emboj.2010.349","volume":"30","author":"S Brabletz","year":"2011","unstructured":"Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E et al. The ZEB1\/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J 2011; 30: 770\u2013782.","journal-title":"EMBO J"},{"key":"BFonc2012565_CR30","doi-asserted-by":"publisher","first-page":"e28688","DOI":"10.1371\/journal.pone.0028688","volume":"6","author":"M Mazda","year":"2011","unstructured":"Mazda M, Nishi K, Naito Y, Ui-Tei K . E-cadherin is transcriptionally activated via suppression of ZEB1 transcriptional repressor by small RNA-mediated gene silencing. PLoS ONE 2011; 6: e28688.","journal-title":"PLoS ONE"},{"key":"BFonc2012565_CR31","doi-asserted-by":"publisher","first-page":"7972","DOI":"10.1158\/0008-5472.CAN-07-1058","volume":"67","author":"GJ Hurteau","year":"2007","unstructured":"Hurteau GJ, Carlson JA, Spivack SD, Brock GJ . Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 2007; 67: 7972\u20137976.","journal-title":"Cancer Res"},{"key":"BFonc2012565_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1158\/0008-5472.CAN-07-5682","volume":"68","author":"S Spaderna","year":"2008","unstructured":"Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 2008; 68: 537\u2013544.","journal-title":"Cancer Res"},{"key":"BFonc2012565_CR33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/sj.onc.1209808","volume":"26","author":"HL Chua","year":"2007","unstructured":"Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H . NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 2007; 26: 711\u2013724.","journal-title":"Oncogene"},{"key":"BFonc2012565_CR34","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/jnci\/djr224","volume":"103","author":"LA Edwards","year":"2011","unstructured":"Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C et al. Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst 2011; 103: 1162\u20131178.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2012565_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/cr.2010.70","volume":"20","author":"MI Almeida","year":"2010","unstructured":"Almeida MI, Reis RM, Calin GA . MYC-microRNA-9-metastasis connection in breast cancer. Cell Res 2010; 20: 603\u2013604.","journal-title":"Cell Res"},{"key":"BFonc2012565_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nature10661","volume":"481","author":"KJ Png","year":"2011","unstructured":"Png KJ, Halberg N, Yoshida M, Tavazoie SF . A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 2011; 481: 190\u2013194.","journal-title":"Nature"},{"key":"BFonc2012565_CR37","doi-asserted-by":"publisher","first-page":"10051","DOI":"10.1074\/jbc.M111.335000","volume":"287","author":"Y Teng","year":"2012","unstructured":"Teng Y, Ngoka L, Mei Y, Lesoon L, Cowell JK . HSP90 and HSP70 proteins are essential for stabilization and activation of WASF3 metastasis-promoting protein. J Biol Chem 2012; 287: 10051\u201310059.","journal-title":"J Biol Chem"},{"key":"BFonc2012565_CR38","doi-asserted-by":"publisher","first-page":"E905","DOI":"10.1002\/ijc.27631","volume":"131","author":"P Ghoshal","year":"2012","unstructured":"Ghoshal P, Teng Y, Lesoon L, Cowell JK . Hypoxia\u2014induced upregulation of the WASF3 metastasis associated gene leads to enhanced invasion in breast cancer cells. Int J Cancer 2012; 131: E905\u2013E915.","journal-title":"Int J Cancer"},{"key":"BFonc2012565_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2131","volume":"7","author":"H Peinado","year":"2007","unstructured":"Peinado H, Olmeda D, Cano A . Snail Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415\u2013428.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012565_CR40","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA . Epithelial\u2013mesenchymal transitions in development and disease. Cell 2009; 139: 871\u2013890.","journal-title":"Cell"},{"key":"BFonc2012565_CR41","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","volume":"69","author":"T Arumugam","year":"2009","unstructured":"Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, Abbruzzese JL et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 2009; 69: 5820\u20135828.","journal-title":"Cancer Res"},{"key":"BFonc2012565_CR42","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1349-7006.2010.01654.x","volume":"101","author":"S Kurisu","year":"2010","unstructured":"Kurisu S, Takenawa T . WASP and WAVE family proteins: friends or foes in cancer invasion? Cancer Sci 2010; 101: 2093\u20132104.","journal-title":"Cancer Sci"},{"key":"BFonc2012565_CR43","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12: R68.","journal-title":"Breast Cancer Res"},{"key":"BFonc2012565_CR44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","volume":"10","author":"RM Neve","year":"2006","unstructured":"Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006; 10: 515\u2013527.","journal-title":"Cancer Cell"},{"key":"BFonc2012565_CR45","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/dna.1996.15.643","volume":"15","author":"AM Cabanillas","year":"1996","unstructured":"Cabanillas AM, Darling DS . Alternative splicing gives rise to two isoforms of Zfhep, a zinc finger\/homeodomain protein that binds T3-response elements. DNA Cell Biol 1996; 15: 643\u2013651.","journal-title":"DNA Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2012565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012565","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:35:04Z","timestamp":1647891304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,14]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1,9]]}},"alternative-id":["BFonc2012565"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.565","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,14]]},"assertion":[{"value":"3 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}